Indeed, adoptive transfer of in vitro-expanded CD8+ T cells can cause tumour regression in the clinical setting.4, 5 These seminal observations have sparked great interest in the use of cellular therapy to combat cancer.6, 7 However, a number of obstacles preclude the widespread use of this approach. The gene discussed is CD8A; the disease is neoplasm.